The Timing for Primary Prevention for ICD in the Current Era of Pharmacotherapy. [PDF]
Shchendrygina A, Yehya A, Skouri H.
europepmc +1 more source
Circulating Immune Cell Signature Analysis in HFpEF Across Species. [PDF]
Kneuer JM+17 more
europepmc +1 more source
Effect of Dapagliflozin Treatment on Index of Cardiac Electrophysiological Balance in Patients With Heart Failure With Reduced Ejection Fraction. [PDF]
Kayhan Y+8 more
europepmc +1 more source
Impact of clinical pathways on enhancing compliance with evidence-based therapies for Heart failure with reduced ejection fraction-A retrospective cohort study. [PDF]
Kanaparthy NS+4 more
europepmc +1 more source
Heart Failure Syndromes: Different Definitions of Different Diseases-Do We Need Separate Guidelines? A Narrative Review. [PDF]
Romanò M.
europepmc +1 more source
Prognostic value of lipid accumulation product in patients with type 2 diabetes mellitus and heart failure with reduced ejection fraction: a retrospective cohort study. [PDF]
Wang H+5 more
europepmc +1 more source
Enhancing quality of life and functional capacity in heart failure patients with iron deficiency: A regional cross-sectional study on intravenous iron therapy in Vietnam. [PDF]
Doan QH, Tran AV, Dinh PTH, Nguyen LD.
europepmc +1 more source
Infection in people with heart failure: an overlooked cause of adverse outcomes. [PDF]
Palin V+6 more
europepmc +1 more source